1
TITLE: A single-institution phase II trial of radiation (RT), temozolomide (TMZ), erlotinib, and bevacizumab for initial treatment of glioblastoma (GBM)
AUTHORS: Jennifer Leigh Clarke; Annette M Molinaro; Nicholas A Butowski; Susan Marina Chang; Joanna J Phillips; Bruno M Costa; Joseph F Costello; Jane E Rabbitt; Valerie A Kivett; Ashley A DeSilva; Michael Prados;
PUBLISHED: 2012, SOURCE: 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 30, ISSUE: 15
INDEXED IN: WOS
2
TITLE: Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcoma
AUTHORS: Nicholas Butowski; Susan M Chang; Kathleen R Lamborn; Mei Yin Polley; Russell Pieper; Joseph F Costello; Scott Vandenberg; Rupa Parvataneni; Angelina Nicole; Patricia K Sneed; Jennifer Clarke; Emily Hsieh; Bruno M Costa; Rui M Reis ; Maria Hristova Kazmierski; Steven J Nicol; Donald E Thornton; Michael D Prados;
PUBLISHED: 2011, SOURCE: NEURO-ONCOLOGY, VOLUME: 13, ISSUE: 12
INDEXED IN: Scopus WOS CrossRef